| Title |
Author |
Type |
Date |
Words |
| 9 Meters Biopharma presents preclinical data on larazotide. |
|
|
May 18, 2022 |
228 |
| Mereo BioPharma announces top-line efficacy data from Astraeus Phase 2 trial. |
|
Clinical report |
May 9, 2022 |
176 |
| Compass Therapeutics Reports Positive Interim Phase 2 Data for ES104 in Combination with Paclitaxel in Biliary Tract Cancers. |
|
|
May 6, 2022 |
423 |
| Point Biopharma confirms no supply shortages of 177Lu-PNT2002 for SPLASH trial. |
|
|
May 5, 2022 |
186 |
| ABVC BioPharma begins enrollment for Phase II Part 2 study of ADHD medicine. |
|
Clinical report |
Apr 28, 2022 |
161 |
| Point Biopharma announces first patient dosed in EU in Phase 3 SPLASH trial. |
|
|
Apr 26, 2022 |
181 |
| Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial. |
|
|
Apr 16, 2022 |
229 |
| GT Biopharma presents preclinical data at AACR on GTB-5550. |
|
|
Apr 11, 2022 |
298 |
| Biogen submits final protocol for ADUHELM Phase 4 ENVISION trial to FDA. |
|
|
Mar 30, 2022 |
242 |
| Sinovac approved for pediatric Covid vaccination in the Philippines. |
|
|
Mar 24, 2022 |
547 |
| Paradigm Biopharmaceuticals Initiates a Phase 3 Clinical Trial in Knee Osteoarthritis Across the US. |
|
|
Mar 17, 2022 |
524 |
| Supporting COVID vaccine seed preparation for pre-clinical trial. |
|
|
Mar 16, 2022 |
290 |
| Supporting COVID vaccine seed preparation for pre-clinical trial. |
|
|
Mar 16, 2022 |
285 |
| Biogen announces long-term phase 3 data on ADUHELM. |
|
|
Mar 16, 2022 |
263 |
| Eucure Biopharma doses first patient in phase one multi-regional clinical trial of YH002 in combination with YH001 in Australia. |
|
|
Mar 9, 2022 |
156 |
| Eucure Biopharma doses first patient in phase one multi-regional clinical trial of YH002 in combination with YH001 in Australia. |
|
|
Mar 9, 2022 |
155 |
| Elpiscience Receives China Clearance of IND Application for Anti-CD39 Monoclonal Antibody ES002. |
|
|
Feb 11, 2022 |
220 |
| Covaxin now a universal COVID vaccine for adults, children: Bharat Biotech. |
|
|
Jan 29, 2022 |
311 |
| Arcturus reports neutralizing antibody immune response to the SARS-CoV-2 Omicron variant from ARCT-154 and ARCT-165 booster clinical trial. |
|
|
Jan 26, 2022 |
256 |
| Arcturus reports neutralizing antibody immune response to the SARS-CoV-2 Omicron variant from ARCT-154 and ARCT-165 booster clinical trial. |
|
|
Jan 26, 2022 |
255 |
| Pfizer-BioNTech begin Omicron vaccine trial. |
|
|
Jan 26, 2022 |
436 |
| Elpiscience Announces First Patient Dosed in US Phase I Clinical Trial of Anti-CD39 Monoclonal Antibody ES002 for Treatment of Advanced Solid Tumors. |
|
|
Jan 20, 2022 |
255 |
| Sutro Biopharma announces STRO-002 Phase 1 Study interim data for advanced ovarian cancer patients. |
|
|
Jan 6, 2022 |
203 |
| Sutro Biopharma announces STRO-002 Phase 1 Study interim data for advanced ovarian cancer patients. |
|
|
Jan 6, 2022 |
204 |
| CanSinoBIO's COVID-19 vaccine found 57.5% effective in Phase III trial. |
|
|
Dec 24, 2021 |
258 |
| CanSinoBIO's COVID-19 vaccine found 57.5% effective in Phase III trial. |
|
|
Dec 24, 2021 |
257 |
| First School-Age Participants Enrolled in BPZE1 Pertussis Vaccine Phase 2b SUPER Clinical Trial. |
|
|
Dec 21, 2021 |
592 |
| Transgene, NEC Tout Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine. |
|
|
Nov 23, 2021 |
1363 |
| Positive results shown for vTv type 1 diabetes drug. |
|
|
Nov 22, 2021 |
995 |
| 4 vaccine makers submit EUA application for COVID-19 vaccine booster shot---PH FDA. |
|
|
Nov 3, 2021 |
529 |
| Landos Biopharma announces FDA clearance of IND for LABP-105 for RA. |
|
|
Nov 2, 2021 |
217 |
| Landos Biopharma announces first subject dosed in Phase 1 study of LABP-104. |
|
|
Oct 28, 2021 |
218 |
| Gilead and Merck to begin Phase 2 clinical study of islatravir and lenacapavir. |
|
|
Oct 26, 2021 |
170 |
| Matinas BioPharma initiates dosing in Phase 1 study of MAT2501. |
|
|
Oct 21, 2021 |
300 |
| Medigen's Phase II MVC-COV1901 vaccine data published in The Lancet Respiratory Medicine. |
|
|
Oct 15, 2021 |
257 |
| Medigen's Phase II MVC-COV1901 vaccine data published in The Lancet Respiratory Medicine. |
|
|
Oct 15, 2021 |
258 |
| First Wave BioPharma doses first patient in Phase 2b trial of niclosamide. |
|
|
Oct 14, 2021 |
292 |
| Africa sets sights on innovative mRNA jab to help meet vaccine gap. |
|
|
Oct 13, 2021 |
716 |
| Kiromic BioPharma Forges Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers. |
|
|
Oct 13, 2021 |
444 |
| Landos Biopharma announces FDA clearance of IND for LABP-104. |
|
|
Oct 11, 2021 |
281 |
| Geron reports publication of IMbark Phase 2 data in Annals of Hematology. |
|
|
Oct 11, 2021 |
256 |
| Kinnate Biopharma details two-part Phase 1 trial design for KIN-2787. |
|
|
Oct 7, 2021 |
310 |
| 8 applications for COVID-19 vaccine clinical trials so far approved - DOST. |
|
|
Oct 5, 2021 |
522 |
| RedHill Biopharma announces more data on opaganib global Phase 2/3 study. |
|
Clinical report |
Oct 4, 2021 |
446 |
| Dynavax, US DOD announce collaboration to develop plague vaccine. |
|
|
Oct 4, 2021 |
295 |
| Enteris BioPharma announces completion of Phase 1 trial of Peptelligence. |
|
|
Oct 4, 2021 |
221 |
| Study: Biovanta treats inflammation safely and effectively. |
|
|
Oct 4, 2021 |
543 |
| Scopus BioPharma's Duet Therapeutic to present preclinical data. |
|
|
Sep 29, 2021 |
236 |
| VBI Vaccines Posts New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern. |
|
Clinical report |
Sep 29, 2021 |
385 |
| First Wave BioPharma begins patient screening for Phase 2b trial of niclosamide. |
|
Clinical report |
Sep 28, 2021 |
237 |
| Impel's Trudhesa spray approved for acute migraines. |
|
|
Sep 20, 2021 |
855 |
| Three things to know about the Semglee biosimilar. |
McGowan, Sean |
|
Sep 20, 2021 |
982 |
| Semglee's success may be limited. |
|
|
Sep 20, 2021 |
593 |
| FDA seeks further data on teplizumab from Provention. |
|
|
Sep 20, 2021 |
800 |
| RedHill Biopharma announces preliminary data from Phase 2/3 study with opaganib. |
|
|
Sep 14, 2021 |
200 |
| Kinnate Biopharma presents preclinical data on FGFR inhibitor candidate KIN-3248. |
|
|
Sep 13, 2021 |
262 |
| AzurRx BioPharma activates trial sites in India for Phase 2 RESERVOIR trial. |
|
Clinical report |
Sep 10, 2021 |
200 |
| Benitec Biopharma provides overview of BB-301 1b/2a clinical trial design. |
|
Clinical report |
Sep 8, 2021 |
265 |
| LATEST COMPANY NEWS. |
|
|
Aug 25, 2021 |
15928 |
| Kadmon says belumosudil 200 mg once daily QD tablets available in U.S. |
|
|
Aug 19, 2021 |
235 |
| Moderna considers including Australian children in Covid-19 vaccine trial. |
|
|
Aug 13, 2021 |
349 |
| NRx begins Phase 2b trial of Israel's BriLife Vaccine for COVID-19 in the Nation of Georgia. |
|
|
Aug 10, 2021 |
254 |
| NRx begins Phase 2b trial of Israel's BriLife Vaccine for COVID-19 in the Nation of Georgia. |
|
|
Aug 10, 2021 |
255 |
| Don't limit innovation; it's the only route to a healthier world. |
O'Brien, John |
|
Aug 9, 2021 |
766 |
| Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine. |
|
|
Aug 6, 2021 |
580 |
| Biogen announces results from Phase 3b NOVA study evaluating natalizumab. |
|
|
Aug 2, 2021 |
359 |
| Biogen, Eisai announce trial design for ICARE AD-US trial. |
|
Clinical report |
Jul 29, 2021 |
294 |
| ARCA Biopharma announce paper on Genecaro Phase 2b results. |
|
|
Jul 28, 2021 |
217 |
| Infinity Pharmaceuticals gives updated data from Phase 2 MARIO-275 trial for UC. |
|
Clinical report |
Jul 27, 2021 |
386 |
| Landos Biopharma to present Phase 3 data of omilancor in UC at UEGW. |
|
|
Jul 22, 2021 |
280 |
| Meissa to release positive preclinical data of Intranasal COVID-19 at ASV 2021 on 22 July 2021. |
|
|
Jul 20, 2021 |
238 |
| Meissa to release positive preclinical data of Intranasal COVID-19 at ASV 2021 on 22 July 2021. |
|
|
Jul 20, 2021 |
237 |
| Meissa Posts Preclinical Data on Intranasal COVID-19 Vaccine Showing Protection from SARS-CoV-2 Challenge after a Single Dose. |
|
|
Jul 20, 2021 |
474 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
155 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
156 |
| ARCA Biopharma provides update on ASPEN-COVID-19 Phase 2b clinical trial. |
|
|
Jul 13, 2021 |
269 |
| Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. |
|
|
Jul 7, 2021 |
258 |
| Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. |
|
|
Jul 7, 2021 |
257 |
| FDA: Sinovac seeks to expand use of its COVID-19 vaccine on children ages 3 to 17. |
|
|
Jul 7, 2021 |
540 |
| LATEST COMPANY NEWS. |
|
|
Jul 7, 2021 |
22907 |
| Priority given to vaccine production, science application in health sector. |
|
|
Jul 6, 2021 |
379 |
| Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. |
|
|
Jul 6, 2021 |
270 |
| Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. |
|
|
Jul 6, 2021 |
271 |
| New Alzheimer's drug welcomed. |
|
|
Jul 5, 2021 |
1463 |
| HDT Bio Receives Notice to Proceed from FDA for US Phase 1 Clinical Trial of RNA COVID-19 Vaccine. |
|
|
Jul 1, 2021 |
430 |
| VBI Vaccines Touts Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19. |
|
|
Jun 29, 2021 |
400 |
| Gilead submits NDA to FDA for lenacapavir. |
|
|
Jun 28, 2021 |
162 |
| Seven and Eight Biopharmaceuticals Inc. Announces the First Patient Treated in a First-in-Human Clinical Trial of the TLR7/8 Dual Agonist BDB018 in Advanced Solid Tumors. |
|
|
Jun 23, 2021 |
271 |
| RedHill Biopharma announces presentation of oral opaganib phase 2 data. |
|
Clinical report |
Jun 21, 2021 |
367 |
| Sage Therapeutics, Biogen Post Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder. |
|
Financial report |
Jun 17, 2021 |
996 |
| Geron says IMbark Phase 2 data published in Journal of Clinical Oncology. |
|
Clinical report |
Jun 17, 2021 |
231 |
| Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA. |
|
|
Jun 14, 2021 |
212 |
| Orgenesis says enrollment is underway for a Phase 2 rotator cuff repair study of its Tissue Genesis Icellator. |
|
|
Jun 11, 2021 |
362 |
| Biogen's hefty price tag for new drug forecast to spark Alzheimer's research resurgence. |
|
|
Jun 10, 2021 |
539 |
| Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. |
|
|
Jun 10, 2021 |
287 |
| Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. |
|
|
Jun 10, 2021 |
288 |
| RedHill Biopharma completes enrollment of oral opaganib phase 2/3 COVID-19 study. |
|
Clinical report |
Jun 7, 2021 |
213 |
| Incyte, MorphoSys announce three-year results from Phase 2 L-MIND study. |
|
|
Jun 4, 2021 |
222 |
| Kinnate Biopharma presents preclinical data from KIN-2787. |
|
|
Jun 4, 2021 |
233 |
| Achilles Therapeutics presents phase I/IIa clinical trial design of CHIRON. |
|
|
Jun 4, 2021 |
190 |
| Can-Fite BioPharma to initiate phase IIb NASH study on Namodenoson. |
|
|
Jun 2, 2021 |
212 |
| Biogen, Bio-Thera announce results from Phase 3 study of BAT1806. |
|
|
Jun 1, 2021 |
198 |
| Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. |
|
|
May 25, 2021 |
209 |
| Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. |
|
|
May 25, 2021 |
208 |
| AzurRx BioPharma announces interim data from phase 2 trial of MS1819. |
|
|
May 13, 2021 |
242 |
| First Patient Dosed in FIREFLY-1 Pivotal Phase 2 Clinical Trial of DAY101 in Pediatric Progressive Low-Grade Glioma. |
|
|
May 12, 2021 |
895 |
| GT Biopharma provides update on Phase 2 TriKE product candidate trial. |
|
|
May 12, 2021 |
229 |
| Qpex Biopharma Initiates Phase 1 Study of ORAvance for Oral Treatment of Drug-Resistant Gram-Negative Bacterial Infections. |
|
Drug overview |
May 12, 2021 |
448 |
| Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. |
|
|
May 10, 2021 |
195 |
| Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. |
|
|
May 10, 2021 |
193 |
| Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. |
|
|
May 10, 2021 |
194 |
| Cue Biopharma announces interim clinical data on phase 1 study of CUE-101. |
|
|
May 10, 2021 |
203 |
| FDA approves Orgenesis IDE for pilot clinical trial of Tissue Genesis Icellator2. |
|
|
May 6, 2021 |
184 |
| First Healthy Volunteers Dosed in Phase I/II Trials of Unique COVID-19 RNA Vaccine in India. |
|
|
May 4, 2021 |
408 |
| Covid-19 vaccine trial plea for young people. |
|
|
Apr 28, 2021 |
266 |
| New trial to explore how plant-derived Covid vaccine could work. |
|
|
Apr 20, 2021 |
411 |
| Wales to take part in UK trial for plant-derived Covid-19 vaccine; The vaccine has already been through early phase human studies and now requires testing on a large scale. |
By, Mark Smith |
|
Apr 19, 2021 |
673 |
| MVP eyes stake in vaccine project, says Glovax CEO. |
|
|
Apr 19, 2021 |
857 |
| First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis. |
|
|
Apr 15, 2021 |
422 |
| VBI Vaccines Releases Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic Candidate. |
|
|
Apr 13, 2021 |
374 |
| China approves new COVID-19 vaccine for clinical trials. |
|
|
Apr 12, 2021 |
173 |
| Korean firm sets PH vaccine clinical trial. |
|
|
Apr 9, 2021 |
715 |
| Intravacc reports encouraging preclinical data for SARS-CoV-2 nose spray vaccine, with significant advantages over injectables. |
|
|
Apr 7, 2021 |
221 |
| Valneva gives UK vaccine progamme another boost with strong trial result. |
|
|
Apr 7, 2021 |
424 |
| Intravacc reports encouraging preclinical data for SARS-CoV-2 nose spray vaccine, with significant advantages over injectables. |
|
|
Apr 7, 2021 |
220 |
| Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover. |
|
|
Apr 6, 2021 |
532 |
| Novavax commences crossover arms in two COVID-19 vaccine clinical trials. |
|
|
Apr 6, 2021 |
159 |
| Novavax commences crossover arms in two COVID-19 vaccine clinical trials. |
|
|
Apr 6, 2021 |
158 |
| AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide. |
|
|
Apr 6, 2021 |
182 |
| Landos Biopharma announces FDA clearance of IND application for Omilancor. |
|
|
Apr 6, 2021 |
188 |
| BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. |
|
|
Mar 25, 2021 |
269 |
| BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. |
|
|
Mar 25, 2021 |
270 |
| Dynavax doses first patient in Phase 2/3 trial for COVID-19 vaccine candidate. |
|
Clinical report |
Mar 24, 2021 |
215 |
| AzurRx BioPharma completes enrollment in Phase 2 trial of MS1819. |
|
|
Mar 22, 2021 |
249 |
| Twist Bioscience releases preclinical data on GLP-1R antibodies. |
|
|
Mar 22, 2021 |
330 |
| GT Biopharma updates interim results of GTB-3550 clinical trial. |
|
|
Mar 17, 2021 |
188 |
| Gilead, US Merck to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV. |
|
|
Mar 16, 2021 |
969 |
| Phase III REMDACTA Trial of Actemra Plus Veklury in Patients with Severe COVID-19 Pneumonia Does Not Meet Primary Endpoint. |
|
Clinical report |
Mar 11, 2021 |
727 |
| VBI Vaccines Starts Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902. |
|
Clinical report |
Mar 10, 2021 |
385 |
| Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. |
|
|
Mar 10, 2021 |
262 |
| Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. |
|
|
Mar 10, 2021 |
261 |
| Indian vaccine maker to start clinical trials in Philippines. |
|
|
Mar 7, 2021 |
327 |
| Transgene, BioInvent Enroll First Patient in Phase I/IIa Trial of Novel Oncolytic Virus BT-001 in Solid Tumors. |
|
|
Mar 2, 2021 |
846 |
| PH-SoKor firm offers 40 M doses of COVID vaccines 50 percent cheaper. |
|
|
Mar 1, 2021 |
963 |
| Garin calls for review of FDA recommendation against Sinovac vaccine. |
|
|
Feb 24, 2021 |
539 |
| GlaxoSmithKline and Sanofi to push ahead with phase II trial of Covid-19 vaccine. |
|
|
Feb 23, 2021 |
565 |
| TOP NEWS: Sanofi, GSK Begin Covid Vaccine Candidate Phase Two Study. |
|
|
Feb 22, 2021 |
201 |
| Vaccine suppliers with EUA may start phase 3 trials. |
|
|
Feb 22, 2021 |
359 |
| Sinovac Releases Phase III Results of Its COVID-19 Vaccine. |
|
|
Feb 5, 2021 |
411 |
| Vaccine developers to be held responsible for clinical trial injury -- Dela Pena. |
|
|
Feb 4, 2021 |
375 |
| RedHill Biopharma receives unanimous support from DSMB for global Phase 2/3 trial of opaganib. |
|
|
Feb 2, 2021 |
556 |
| RedHill Biopharma receives unanimous support from DSMB for global Phase 2/3 trial of opaganib. |
|
|
Feb 2, 2021 |
554 |
| China's CanSino to advance Phase III trials of its COVID-19 vaccine candidate. |
|
|
Feb 1, 2021 |
170 |
| China's CanSino to advance Phase III trials of its COVID-19 vaccine candidate. |
|
|
Feb 1, 2021 |
166 |
| Clover partners with Dynavax for planned Global Phase 2/3 efficacy trial of adjuvanted COVID-19 vaccine candidate. |
|
|
Feb 1, 2021 |
253 |
| Clover partners with Dynavax for planned Global Phase 2/3 efficacy trial of adjuvanted COVID-19 vaccine candidate. |
|
|
Feb 1, 2021 |
249 |
| Drug firm to hold Covid vaccine clinical trial in Bacolod City. |
|
|
Jan 28, 2021 |
299 |
| BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. |
|
|
Jan 28, 2021 |
168 |
| BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. |
|
|
Jan 28, 2021 |
167 |
| BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. |
|
|
Jan 28, 2021 |
163 |
| MorphoSys, I-Mab Dose First Patient In Phase One Study Of Cancer Drug. |
|
|
Jan 26, 2021 |
223 |
| Phase 1B begins Monday But vaccines at start still expected to be scarce. |
Jake Griffin jgriffin@dailyherald.com |
|
Jan 23, 2021 |
929 |
| Phase 1B begins Monday But vaccines at start still expected to be scarce Phase: Counties now taking or will take registrations via websites. |
Jake Griffin jgriffin@dailyherald.com |
|
Jan 23, 2021 |
929 |
| Next phase of vaccinations begins Monday, but state warns shots are still scarce. |
Jake Griffin jgriffin@dailyherald.com |
|
Jan 23, 2021 |
934 |
| LIST: Target trial sites in PH for Janssen, Clover, Sinovac vaccines. |
|
|
Jan 22, 2021 |
356 |
| Technology Fully Tapped in the Race for the Much-awaited Vaccine. |
|
|
Jan 21, 2021 |
544 |
| Sinovac use eyed in 'specific sector' during PH clinical trials --- DOH. |
|
|
Jan 20, 2021 |
397 |
| Duterte to senators: You want Pfizer? We'll order for you. |
|
|
Jan 19, 2021 |
503 |
| Transgene, BioInvent Receive Approval from ANSM to Proceed with Phase I/IIa Trial of Anti-CTLA4-armed Oncolytic Virus BT-001 in Solid Tumors. |
|
|
Jan 19, 2021 |
836 |
| Dr. Reddy's Laboratories to begin phase 3 study of Sputnik V vaccine in India. |
|
|
Jan 18, 2021 |
230 |
| Dr. Reddy's Laboratories to begin phase 3 study of Sputnik V vaccine in India. |
|
|
Jan 18, 2021 |
231 |
| Janssen, Clover pushing through with Philippine trials. |
|
|
Jan 15, 2021 |
649 |
| Vaccine Publishes Results from a Phase 4 Study of VBI Vaccines' Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine. |
|
|
Jan 15, 2021 |
553 |
| Poe urges faster processing of emergency use authority applications from vaccine makers. |
|
|
Jan 11, 2021 |
636 |
| BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. |
|
|
Jan 11, 2021 |
224 |
| BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. |
|
|
Jan 11, 2021 |
223 |
| BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. |
|
|
Jan 11, 2021 |
219 |
| Indian vaccine maker denies trial 'irregularities'. |
Sanjay Kumar |
|
Jan 9, 2021 |
766 |
| RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. |
|
|
Jan 8, 2021 |
476 |
| FDA okays Chinese firm's vaccine clinical trials. |
|
|
Jan 8, 2021 |
263 |
| China's Clover gets nod for Philippine trials. |
|
|
Jan 8, 2021 |
400 |
| RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. |
|
|
Jan 8, 2021 |
474 |
| Icon Supports Pfizer, BioNTech on the Investigational COVID-19 Vaccine Trial. |
|
|
Jan 5, 2021 |
314 |
| RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. |
|
Clinical report |
Jan 4, 2021 |
316 |
| RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. |
|
Clinical report |
Jan 4, 2021 |
312 |
| China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. |
|
|
Dec 30, 2020 |
221 |
| China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. |
|
|
Dec 30, 2020 |
225 |
| As vaccines are rolled out, questions remain. |
|
|
Dec 27, 2020 |
734 |
| Analyzing the Facts-ination: #WhenwillwebeaVaccineNation? |
|
|
Dec 26, 2020 |
964 |
| Korea shows little progress in vaccine development. |
|
|
Dec 23, 2020 |
629 |
| Transgene and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT-001 in Solid Tumors. |
|
|
Dec 22, 2020 |
561 |
| COVID-19: Australia cancels order for vaccine as trial stumbles. |
|
|
Dec 21, 2020 |
429 |
| France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. |
|
|
Dec 16, 2020 |
248 |
| France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. |
|
|
Dec 16, 2020 |
252 |
| Tests to start for new vaccine; CLINICAL TRIALS TO BEGIN IN NEWCASTLE. |
KATIE DICKINSON Reporter katie.dickinson@ncjmedia.co.uk |
|
Dec 16, 2020 |
333 |
| First Subject Dosed in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China. |
|
|
Dec 11, 2020 |
1179 |
| No more Philippine clinical trials for AstraZeneca. |
|
|
Dec 11, 2020 |
778 |
| Oxford/Astra first to publish final-stage vaccine trial results. |
|
|
Dec 9, 2020 |
674 |
| Clover Biopharmaceuticals Touts Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates. |
|
|
Dec 7, 2020 |
511 |
| DOST: Trials for China's Sinovac, Clover may start end-2020 or early 2021. |
|
|
Nov 27, 2020 |
380 |
| VBI Vaccines Touts Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection. |
|
|
Nov 19, 2020 |
505 |
| 2nd vaccine 94.5% effective, trial shows. |
MARTIN BAGOT |
|
Nov 17, 2020 |
180 |
| UK to lead final trials of vaccine. |
|
|
Nov 16, 2020 |
215 |
| 6,000 UK participants sought for final-stage Covid-19 vaccine trials. |
|
|
Nov 16, 2020 |
241 |
| 6,000 volunteers needed for final stage test of Covid vaccine; So far around 25,000 people in the UK have participated in vaccine trials. |
By, Neil Shaw |
|
Nov 16, 2020 |
636 |
| Johnson & Johnson Seeks 6,000 UK Participants For Vaccine Trial. |
|
|
Nov 16, 2020 |
641 |
| Medicago and GSK to begin final Covid-19 vaccine trials. |
|
|
Nov 13, 2020 |
333 |
| Brazil allows trials of Chinese vaccine to resume. |
|
|
Nov 12, 2020 |
511 |
| China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. |
|
|
Nov 10, 2020 |
217 |
| China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. |
|
|
Nov 10, 2020 |
221 |
| Brazil halts trials of Chinese Covid-19 vaccine. |
|
|
Nov 10, 2020 |
574 |
| AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. |
|
|
Nov 5, 2020 |
277 |
| AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. |
|
|
Nov 5, 2020 |
281 |
| Dr. Reddy's Partners On Sputnik V vaccine Clinical Trials in India. |
|
|
Oct 29, 2020 |
345 |
| Precision NanoSystems Will Receive CDN 18.2m from the government of Canada to Develop an RNA Vaccine for COVID-19. |
|
|
Oct 26, 2020 |
299 |
| Cyclacel Pharmaceuticals presents Phase 1 data on fadraciclib. |
|
|
Oct 26, 2020 |
330 |
| RedHill Biopharma presents new data from Talicia Phase 3 studies. |
|
|
Oct 26, 2020 |
367 |
| US gives full approval to antiviral remdesivir to treat Covid-19. |
|
|
Oct 23, 2020 |
542 |
| Merck Touts Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine. |
|
|
Oct 22, 2020 |
906 |
| Trump gets Gilead drug, Regeneron antibody mix. |
|
|
Oct 19, 2020 |
841 |
| Mereo BioPharma announces FDA clearance for Phase 1b/2 study of etigilimab. |
|
|
Oct 19, 2020 |
198 |
| 'Change of mind:' China-based pharma firm will not join vaccine trials. |
|
|
Oct 17, 2020 |
305 |
| RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. |
|
|
Oct 15, 2020 |
161 |
| RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. |
|
|
Oct 15, 2020 |
165 |
| China's Sinovac hurdles initial stage of screening for clinical trials in Philippines. |
|
|
Oct 15, 2020 |
307 |
| Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. |
|
|
Oct 14, 2020 |
507 |
| Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. |
|
|
Oct 14, 2020 |
505 |
| Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis. |
|
|
Oct 13, 2020 |
387 |
| Gilead, Galapagos presents data from Phase 2b/3 trial of filgotinib. |
|
|
Oct 12, 2020 |
563 |
| 3 int'l COVID-19 vaccine makers gunning for Phase 3 clinical trials in PH. |
|
|
Oct 8, 2020 |
354 |
| ARCA Biopharma announces FDA approval of IND application for AB201. |
|
|
Oct 7, 2020 |
342 |
| IDMC recommends Can-Fite BioPharma continue Comfort trial, discontinue Acrobat. |
|
|
Oct 6, 2020 |
273 |
| GSK ready with Theraflu portfolio. |
|
|
Oct 5, 2020 |
734 |
| CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. |
|
|
Sep 30, 2020 |
179 |
| CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. |
|
|
Sep 30, 2020 |
175 |
| COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. |
|
|
Sep 29, 2020 |
253 |
| COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. |
|
|
Sep 29, 2020 |
249 |
| Egypt's health minister takes part in clinical trial of Chinese coronavirus vaccine candidate. |
Egypt Today staff |
|
Sep 28, 2020 |
341 |
| India's vaccine capacity will help 'all humanity' - Modi. |
|
|
Sep 27, 2020 |
688 |
| Clover Biopharmaceuticals Touts Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate. |
|
|
Sep 25, 2020 |
683 |
| Spend 94 billion won this year to develop homegrown COVID-19 vaccine. |
|
|
Sep 25, 2020 |
296 |
| UK: Another COVID-19 vaccine enters final stage trials. |
|
|
Sep 25, 2020 |
234 |
| Sinovac's Coronavac, SARS-CoV-2 Vaccine, Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children. |
|
|
Sep 24, 2020 |
307 |
| Sinovac Starts Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey. |
|
|
Sep 22, 2020 |
485 |
| Seattle Genetics, Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020. |
|
|
Sep 21, 2020 |
570 |
| Seattle Genetics, Genmab presents data from innovaTV 204 phase 2 trial. |
|
|
Sep 21, 2020 |
482 |
| Genentech presents new data from multiple Phase III studies of Tecentriq in TNBC. |
|
|
Sep 20, 2020 |
452 |
| Astellas Pharma, Seattle Genetics announce Padcev trial meets primary endpoint. |
|
|
Sep 18, 2020 |
216 |
| I-MAB, MorphoSys announce FDA clearance of IND for MOR210/TJ210. |
|
|
Sep 17, 2020 |
195 |
| Bahrain crown prince volunteers in Covid-19 vaccine trial. |
Arab News |
|
Sep 16, 2020 |
218 |
| Phase 3 Testing: Is The Vaccine Safe? |
Claudia Z |
|
Sep 15, 2020 |
600 |
| Vaxart announces FDA clearance of IND application for oral COVID-19 vaccine. |
|
|
Sep 14, 2020 |
181 |
| AstraZeneca, Oxford University Resume Covid-19 Vaccine Trials In UK. |
|
|
Sep 14, 2020 |
267 |
| 7 firms sign CDA for vaccine trial candidates. |
|
|
Sep 10, 2020 |
387 |
| AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness of participant. |
ANI |
|
Sep 9, 2020 |
563 |
| Genentech initiates Phase III clinical trial programs for fenebrutinib, Ocrevus. |
|
|
Sep 9, 2020 |
539 |
| Sutro Biopharma reports Phase 1 data of STRO-002 in ovarian cancer. |
|
|
Sep 9, 2020 |
240 |
| Strongbridge Biopharma announces 'positive' results from Phase 3 RECORLEV study. |
|
Clinical report |
Sep 8, 2020 |
171 |
| Strongbridge Biopharma expects to submit RECORLEV NDA in 1Q21. |
|
Clinical report |
Sep 8, 2020 |
172 |
| South Korea to spend W171 billion to develop COVID-19 vaccine. |
|
|
Sep 4, 2020 |
265 |
| Florence Healthcare Supports Pfizer's COVID-19 Vaccine Clinical Trials with Extensive Connectivity Platform. |
|
|
Sep 3, 2020 |
263 |
| Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial. |
|
|
Sep 3, 2020 |
188 |
| TAKE YOUR BEST SHOT: The whole world wants a vaccine, but countries will naturally try to secure a supply for themselves first. |
Regalado, Antonio |
|
Sep 1, 2020 |
2302 |
| Taiwan approves human trials for 2nd coronavirus vaccine. |
|
|
Aug 28, 2020 |
245 |
| Scancell Holdings consortium gets government backing for Covid trial. |
|
|
Aug 28, 2020 |
283 |
| Taiwan's 1st coronavirus vaccine on track for Phase II trials in Nov. |
|
|
Aug 27, 2020 |
343 |
| BeiGene to develop, manufacture Singlomics anti-COVID-19 antibodies. |
|
Clinical report |
Aug 27, 2020 |
215 |
| Mereo BioPharma initiates Phase 1b/2 trial with alvelestat in COVID-19. |
|
|
Aug 25, 2020 |
289 |
| Matinas BioPharma publishes data from Phase 1 EnACT study of MAT2203 to treat cryptococcal meningitis. |
|
|
Aug 21, 2020 |
450 |
| Taiwan's 1st coronavirus vaccine approved for human trials. |
|
|
Aug 18, 2020 |
327 |
| A shot for humanity: UAE's vaccine trial for Covid-19. |
Reach by Gulf News |
|
Aug 14, 2020 |
1056 |
| PH in talks with 16 other vaccine developers for COVID-19, not just Russia -- DOH. |
|
|
Aug 14, 2020 |
869 |
| A shot for humanity: Join UAE's vaccine trial for Covid-19. |
Reach by Gulf News |
|
Aug 13, 2020 |
977 |
| PH panel meets with Russian vaccine manufacturer to discuss clinical trials. |
|
|
Aug 12, 2020 |
375 |
| DOST to meet Russian vaccine maker on possible PH participation in clinical trials. |
|
|
Aug 12, 2020 |
484 |
| Gilead submits NDA to FDA for Veklury for COVID-19 treatment. |
|
Clinical report |
Aug 10, 2020 |
224 |
| US conducts further clinical trial for remdesivir as COVID-19 treatment. |
|
|
Aug 7, 2020 |
525 |
| RedHill Biopharma Phase 2/3 COVID-19 study approved in Mexico. |
|
|
Aug 6, 2020 |
220 |
| Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. |
|
|
Jul 31, 2020 |
188 |
| Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. |
|
|
Jul 31, 2020 |
192 |
| RedHill Biopharma initiates global Phase 2/3 study for COVID-19. |
|
|
Jul 30, 2020 |
196 |
| Genentech Shares Disappointing News on Phase III COVACTA Trial of Actemra in Hospitalized Patients with Severe COVID-19 Associated Pneumonia. |
|
|
Jul 29, 2020 |
915 |
| Cue Biopharma begins dosing Cohort 5 in Phase 1 trial of CUE--101. |
|
|
Jul 28, 2020 |
290 |
| Moderna's BARDA agreement expanded to support Phase 3 trial of COVID vaccine. |
|
|
Jul 26, 2020 |
386 |
| Moderna's BARDA agreement expanded to support larger Phase 3 COVID vaccine trial. |
|
|
Jul 26, 2020 |
386 |
| Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials. |
|
|
Jul 23, 2020 |
257 |
| RedHill Biopharma submits CTAs in Brazil, Mexico for Phase 2/3 COVID-19 program. |
|
|
Jul 22, 2020 |
344 |
| Biogen to initiate Phase 4 study of SPINRAZA in patients treated with Zolgensma. |
|
|
Jul 21, 2020 |
377 |
| 9 Meters Biopharma doses first patients in Phase 1b/2a clinical trial in SBS. |
|
|
Jul 21, 2020 |
213 |
| Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. |
|
|
Jul 16, 2020 |
504 |
| UAE begins world's first phase 3 trial of inactivated Covid vaccine. |
|
|
Jul 16, 2020 |
1003 |
| RedHill Biopharma receives approval for Phase 2/3 COVID-19 study. |
|
|
Jul 16, 2020 |
350 |
| Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. |
|
|
Jul 16, 2020 |
502 |
| Dynavax announces first patients dosed in Phase 1 trial of Medicago's vaccine. |
|
|
Jul 14, 2020 |
277 |
| Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile. |
|
|
Jul 13, 2020 |
546 |
| Biogen initiates new phase 3 study of BAN2401 in preclinical AD. |
|
|
Jul 13, 2020 |
184 |
| Genentech Says New Data from Phase IIIb Study Reinforces Safety Profile of Hemlibra in People with Hemophilia A. |
|
|
Jul 13, 2020 |
681 |
| DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. |
|
|
Jul 10, 2020 |
761 |
| DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. |
|
|
Jul 9, 2020 |
681 |
| Brazil to become testing ground for coronavirus vaccine. |
|
|
Jul 8, 2020 |
732 |
